Novonesis A/S operates through two primary divisions: Food & Health Biosolutions and Planetary Health Biosolutions. The company leverages a vast library of microbial strains and patents to create biological solutions that improve industrial processes, enhance agricultural yields, and develop healthier food products. Its products include enzymes for detergents that enable cold-water washing, solutions for bioenergy production, and probiotics for human and animal health. The company's technologies aim to reduce reliance on fossil-based resources and chemicals across more than 30 industries globally. Novonesis is controlled by Novo Holdings, the investment arm of the Novo Nordisk Foundation.
